image

Membership:  2017 Membership Application Form

Contact Us: Please email vchaumont@cheo.on.ca with your questions or comments so they may be directed to the appropriate person.  Thank you.

………………………………………………………………………………………………………..

Supported by the University of Alberta, the theme of this year’s meeting is “Transplant in Inborn Errors of Metabolism”, with a wide range of topics of interest for clinicians, scientists and trainees. The annual symposium continues to bring together Canadian and International experts with active clinical, research and educational roles in the field of inborn errors of metabolism (IEM). Attendees represent a broad range of expertise, including clinical and laboratory metabolic specialists, geneticists, dieticians, nurses, genetic counselors and basic science researchers.

Call for Abstracts

The Call for Abstracts for the Garrod Symposium 2018 is now open. Deadline for submission is Friday, January 26, 2018. Please click here for more information.

Location and Accommodation

The Fairmont Hotel MacDonald
10065 100 St. NW, Edmonton, AB

The special rate of CDN $229.00 (plus applicable taxes) for a standard guest room (single/double) is available for conference delegates. To avoid disappointment, book your accommodation by calling toll-free: 1.800.257.7544 or Local: 1.780.424.5181. When calling, please specify that you are booking under the Garrod Symposium 2018 room block to receive these reduced rates.  More information

Link to photos from the 2016 meeting
Link to videos fro the 2016 meeting
Link to photos from the 2015 meeting
Final report from the 2015 meeting

………………………………………………………………………………………………………..

An International Registry for Morquio-B Disease hosted at BC Children’s Hospital

Morquio-B-Disease is an ultra-rare form of late-onset GM1-Gangliosidosis, characterized by bone disease resembling Morquio-A Disease.

Various research consortia are currently developing treatments for this condition.

Funding from the Priest Family Foundation (www.morquiob.com) allows us to collect natural history data, which will be most essential for the future design of clinical trials.

If you have patients with Morquio-B-Disease or with late-onset GM1-Gangliosidosis, please contact us.

Every single patient is important.

Sylvia Stockler (PI) sstockler@cw.bc.ca

Maria Boldut (Project Manager) maria.boldut@cw.bc.ca

………………………………………………………………………………………………………..

Rare Diseases: Models & Mechanisms Network

Have you identified a new genetic disease or work on a genetic disease which would merit further research in a model organism? If so, please consult http://rare-diseases-catalyst-network.ca for funding and collaboration opportunities. Letter of Information

………………………………………………………………………………………………………..

Seeking Farber Disease or SMA-PME Patients

Plexcera Therapeutics LLC, a biotech firm which is developing an enzyme replacement therapy for acid ceramidase deficiency, is seeking Farber Disease patients to be part of a clinical trial to commence tentatively in the second half of 2015.

Dr. Alexander Solyom, MD, working with Plexcera, is collecting natural history data on SMA-PME patients and coordinating an international natural history study of Farber Disease including non-transplanted, transplanted, and patients since deceased.

Please contact him for further information at patients@plexcera.com